| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 53 sells. UTHR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | Rothblatt Martine A | 66.0K | $35.53M | - |
| VP | Mahon Paul A | 44.5K | $23.95M | - |
| CEO | 40.5K | $21.81M | -28,500 | |
| VP | 33.5K | $18.03M | - | |
| CFO | Edgemond James | 19.9K | $10.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | Dwek Raymond | Director | Sale+OE | 3,000 | $285.57 | $856,710.00 | -63.2% | +3.1% | - | |
| Apr 17, 2025 | Mahon Paul A47 | EVP &General Counsel | Sale+OE | 11,000 | $283.78 | $3,121,543.06 | -6.1% | +4.7% | - | |
| Apr 14, 2025 | Dwek Raymond | Director | Sale+OE | 3,000 | $285.16 | $855,480.00 | -63.2% | +4.7% | +101.1% | |
| Apr 7, 2025 | Dwek Raymond | Director | Sale+OE | 4,000 | $284.55 | $1,138,200.00 | -69.6% | -0.5% | +93.9% | |
| Apr 3, 2025 | Mahon Paul A47 | EVP &General Counsel | Sale+OE | 11,000 | $306.18 | $3,367,983.80 | -4.1% | -3.9% | +85.5% | |
| Mar 24, 2025 | Thompson Tommy G51 | Director | Sale+OE | 2,500 | $318.80 | $796,990.50 | -22.8% | -10.5% | +66.3% | |
| Mar 19, 2025 | Patusky Christopher50 | Director | Sale+OE | 5,000 | $310.72 | $1,553,584.58 | -19.9% | -10.0% | +65.3% | |
| Mar 10, 2025 | Benkowitz Michael47 | President And COO | Sale+OE | 2,000 | $320.09 | $640,183.75 | -25.1% | +3.3% | +68.7% | |
| Mar 3, 2025 | Benkowitz Michael47 | President And COO | Sale+OE | 9,679 | $311.99 | $3,019,735.65 | -27.0% | +5.0% | +60.8% | |
| Feb 28, 2025 | Kurzweil Ray | Director | Sale+OE | 15,000 | $317.01 | $4,755,151.44 | -9.3% | +0.1% | +57.4% |